Objectives
1. To discuss the newly-validated ACR/EULAR Classification Criteria for IgG4-RD
2. To understand the implications of these criteria for clinical practice
3. To review what is known about the pathophysiology of IgG4-RD and how this knowledge impacts treatment decsions now
Session date:
12/11/2018 - 8:30am to 9:30am CST
Location:
UCMC
Chicago, IL
60637
United States
See map: Google Maps
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Speaker Name:
John Stone